Brookstone Capital Management Sells 13,153 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Brookstone Capital Management trimmed its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 49.7% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 13,291 shares of the healthcare conglomerate's stock after selling 13,153 shares during the quarter. Brookstone Capital Management's holdings in UnitedHealth Group were worth $6,961,000 at the end of the most recent quarter.

A number of other hedge funds also recently bought and sold shares of the company. IFM Investors Pty Ltd lifted its stake in UnitedHealth Group by 8.6% during the 1st quarter. IFM Investors Pty Ltd now owns 189,925 shares of the healthcare conglomerate's stock valued at $99,473,000 after acquiring an additional 14,994 shares during the period. GF Fund Management CO. LTD. lifted its holdings in shares of UnitedHealth Group by 1.8% during the 1st quarter. GF Fund Management CO. LTD. now owns 24,412 shares of the healthcare conglomerate's stock valued at $12,786,000 after buying an additional 420 shares during the period. Hartline Investment Corp lifted its holdings in UnitedHealth Group by 1.1% in the first quarter. Hartline Investment Corp now owns 2,994 shares of the healthcare conglomerate's stock valued at $1,568,000 after acquiring an additional 34 shares during the period. 4J Wealth Management LLC lifted its stake in shares of UnitedHealth Group by 21.7% in the 1st quarter. 4J Wealth Management LLC now owns 840 shares of the healthcare conglomerate's stock worth $440,000 after purchasing an additional 150 shares during the period. Finally, 44 Wealth Management LLC lifted its stake in shares of UnitedHealth Group by 15.4% in the 1st quarter. 44 Wealth Management LLC now owns 1,510 shares of the healthcare conglomerate's stock worth $791,000 after purchasing an additional 201 shares during the period. Institutional investors own 87.86% of the company's stock.

Insider Buying and Selling

In related news, Director Timothy Patrick Flynn purchased 1,533 shares of the business's stock in a transaction dated Wednesday, May 14th. The shares were purchased at an average cost of $320.80 per share, for a total transaction of $491,786.40. Following the completion of the acquisition, the director owned 6,033 shares in the company, valued at approximately $1,935,386.40. This trade represents a 34.07% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Kristen Gil purchased 3,700 shares of the business's stock in a transaction dated Thursday, May 15th. The stock was bought at an average price of $271.17 per share, for a total transaction of $1,003,329.00. Following the completion of the acquisition, the director owned 3,818 shares of the company's stock, valued at approximately $1,035,327.06. The trade was a 3,135.59% increase in their position. The disclosure for this purchase can be found here. Insiders have purchased a total of 109,408 shares of company stock worth $31,607,768 over the last ninety days. Corporate insiders own 0.28% of the company's stock.

UnitedHealth Group Trading Down 1.6%

NYSE UNH traded down $4.80 during trading hours on Monday, hitting $303.75. 9,010,516 shares of the company were exchanged, compared to its average volume of 7,565,898. The stock has a market cap of $275.54 billion, a PE ratio of 12.72, a price-to-earnings-growth ratio of 1.48 and a beta of 0.45. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.71. The stock has a 50-day moving average price of $322.66 and a 200 day moving average price of $445.65. UnitedHealth Group Incorporated has a 52 week low of $248.88 and a 52 week high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. The firm had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. During the same quarter last year, the firm earned $6.91 EPS. Analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th were paid a dividend of $2.21 per share. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date was Monday, June 16th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.91%. UnitedHealth Group's dividend payout ratio is currently 37.02%.

Analysts Set New Price Targets

UNH has been the topic of a number of recent research reports. Piper Sandler decreased their target price on UnitedHealth Group from $552.00 to $353.00 and set an "overweight" rating on the stock in a report on Tuesday, June 3rd. TD Cowen cut shares of UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 target price on the stock. in a research note on Monday, May 19th. Argus downgraded shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a research report on Monday, April 21st. Wells Fargo & Company reissued an "overweight" rating on shares of UnitedHealth Group in a report on Friday, June 6th. Finally, Wolfe Research decreased their price target on UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating on the stock in a report on Tuesday, May 20th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and sixteen have given a buy rating to the company. Based on data from MarketBeat, UnitedHealth Group has an average rating of "Moderate Buy" and an average target price of $415.57.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.